2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Balloon pulmonary angioplasty

Chronic thrombo-embolic pulmonary hypertension

Congenital heart disease

Connective tissue disease

Endothelin receptor antagonists

Guidelines

Left heart disease

Lung disease

Lung transplantation

Phosphodiesterase type 5 inhibitors

Prostacyclin analogues

Prostacyclin receptor agonists

Pulmonary arterial hypertension

Pulmonary endarterectomy

Pulmonary hypertension

Soluble guanylate cyclase stimulators

Endothelin Receptor Antagonists

Humans

Hypertension, Pulmonary

ambrisentan

amlodipine

antiretrovirus agent

beraprost

beta adrenergic receptor blocking agent

bosentan

bosutinib

cyclophosphamide

dasatinib

diltiazem

dipeptidyl carboxypeptidase inhibitor

diuretic agent

endothelin receptor antagonist

enkephalinase inhibitor

felodipine

guanylate cyclase activator

iloprost

interferon

ivabradine

macitentan

methamphetamine

mitomycin

nifedipine

phosphodiesterase V inhibitor

Pneumococcus vaccine

ponatinib

prostacyclin

prostacyclin derivative

riociguat

SARS-CoV-2 vaccine

selexipag

sildenafil

sodium glucose cotransporter 2 inhibitor

tadalafil

treprostinil

abdominal radiography

altitude

angioplasty

anticoagulant therapy

aortic stenosis

aortopulmonary shunt

arterial gas

assisted circulation

biochemical analysis

birth control

blood analysis

BMPR2 gene

cardiopulmonary exercise test

cardiovascular magnetic resonance

chronic kidney failure

chronic obstructive lung disease

chronic thromboembolic pulmonary hypertension

clinical decision making

comorbidity

congenital heart disease

connective tissue disease

contraceptive behavior

coronavirus disease 2019

denervation

digital subtraction angiography

disease association

disease classification

disease control

disease course

disease severity

drug approval

drug design

drug potentiation

drug safety

dynamic contrast enhanced computed tomography

early diagnosis

echocardiography

echography

electrocardiogram

Europe

evidence based practice

exercise

fluid challenge test

follow up

gene

genetic counseling

genetic screening

GRADE approach

health care facility

health care management

health care personnel

heart arrhythmia

heart catheterization

heart failure with preserved ejection fraction

heart failure with reduced ejection fraction

heart left ventricle hypertrophy

heart lung transplantation

heart right ventricle failure

hematologic disease

hemoptysis

human

Human immunodeficiency virus infection

hypoxia

immunology

intensive care unit

interstitial lung disease

iron deficiency anemia

liver transplantation

lung artery pressure

lung embolism

lung emphysema

lung function test

lung hemodynamics

lung transplantation

mediastinitis

metabolic disorder

microangiopathy

mitral valve disease

mortality risk

noninvasive ventilation

oxygen therapy

pathophysiology

patient compliance

patient empowerment

patient-reported outcome

phase 3 clinical trial (topic)

physical activity

pneumococcal infection

portal hypertension

practice guideline

pregnancy

prognosis

psychosocial care

pulmonary artery denervation

pulmonary artery occlusion

pulmonary endarterectomy

pulmonary hypertension

pulmonary tumour thrombotic microangiopathy

rehabilitation care

Review

risk assessment

risk factor

schistosomiasis

surgical technique

systemic disease

systemic sclerosis

telemonitoring

terminal care

thorax radiography

thrombotic microangiopathy

travel

tricuspid valve regurgitation

vaccination

vasoreactivity test

ventilation-perfusion scan

Publikations- och innehållstyp

art (ämneskategori)

ref (ämneskategori)